semaglutide 2.5 mg dosage chart Wegovy Dosing: What Is Weight Loss Switching from semaglutide to tirzepatide

Its all about interrupting a signal

10.1001/archpsyc.63.8.856 234 ZarateC

The rise in reports has added to concerns that the popularity of weight-loss injections is moving faster than public understanding of their risks, especially when the drugs are taken outside regulated healthcare systems.

Semaglutide 2.4 mg (Wegovy): ~15% body weight loss at 68 weeks in clinical trials Tirzepatide 15 mg (Zepbound): ~21% body weight loss at 72 weeks in clinical trials Real-world data shows lower results: Cleveland Clinic research from 2025 found average weight loss of 7.7% with semaglutide and 12.4% with tirzepatide at one year in routine clinical practice